2020 ACS CAN Missouri Policy Forum
CancerTalks: Drug Development and Ensuring Access to New Tests & Treatments
Virtual Event - September 29, 2020
11:00 AM - 12:00 PM
Cancer remains a critical public health problem and how new cures are developed and delivered will continue to change. Getting new and affordable cancer therapies from the research lab to the patient will require collaborative solutions from researchers, business leaders, providers and policy makers. Join ACS CAN for a discussion on what the current drug development landscape looks like and how we can ensure that patients can access the newest tests and treatments.
Speakers for the event:
Michael Kinch, PhD
Associate Vice Chancellor & Director of Center for Research Innovation in Business
Washington University in St. Louis
Joan Malcolm
Director, External Affairs
GRAIL, Inc.
Mark Fleury, PhD
Policy Principal
ACS CAN
Cancer conversation topics will include:
- Drug Development: Advancements in medical research have unleashed new and improved therapies that are revolutionizing cancer care. What is the process for transforming this research into new drugs and therapies? What are the challenges in getting new treatments to the market for patients to access them?
- Access: Understanding and addressing the barriers that prevent patients from having access to tests, drugs and treatments is a crucial step. How can we make sure that patients have access to the tests, drugs and treatments they need?
For more information, including sponsorship opportunities, please contact emily.kalmer@cancer.org. To support this event financially, please make a donation here.
Thank you to our sponsors:
Silver Level Sponsors:
Bristol Myers Squibb
Merck
Novartis
Pfizer
Community Supporter Sponsors:
Genentech
GRAIL
Janssen Oncology
PhRMA